News

Immunovaccine Grants Stock Options

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 20, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical...

Immunovaccine to Present at 6th Annual Biotech Showcase Conference

Immunovaccine to Present at 6th Annual Biotech Showcase Conference HALIFAX, NOVA SCOTIA--(Marketwired - Jan 9, 2014) - Immunovaccine Inc...

Immunovaccine to Present at 6th Annual Biotech Showcase Conference

HALIFAX, NOVA SCOTIA--(Marketwired - Jan. 9, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical...

Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors

Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors HALIFAX, NOVA SCOTIA--(Marketwired - Dec 16, 2013) - Immunovaccine Inc...

Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors

HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 16, 2013) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical...

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013 HALIFAX, NOVA SCOTIA--(Marketwired - Nov 29, 2013...

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 29, 2013) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical...

Immunovaccine Raises $4.2 Million in Private Placement

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 21, 2013) - NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED...

Immunovaccine Announces a Non-Brokered Private Placement of $3.2 million

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 28, 2013) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION...

Immunovaccine Retains B & D Capital Partners For Strategic Investor Relations Services

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 11, 2013) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV), a clinical stage...

Immunovaccine Reports Positive Results from Two Anthrax Studies

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 9, 2013) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV), a clinical stage...

Immunovaccine Announces Management Team Changes

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 3, 2013) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX VENTURE:IMV), a clinical stage...

Immunovaccine Announces Financial Results for the Quarter Ended June 30, 2013

HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 29, 2013) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine...

IIROC Trading Resumption - IMV

IIROC Trading Resumption - IMV Canada NewsWire VANCOUVER, Aug. 2, 2013 VANCOUVER, Aug. 2, 2013 /CNW/ - Trading resumes in: Company: Immunovaccine...

Boards:

Quotes:

Boards

Market Data

Markets

Discover

(IMV)

Professional-Grade Tools, for Individual Investors.

IMV News

Immunovaccine Grants Stock Options

Immunovaccine to Present at 6th Annual Biotech Showcase Conference

Immunovaccine to Present at 6th Annual Biotech Showcase Conference

Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors

Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013

Immunovaccine Raises $4.2 Million in Private Placement

Immunovaccine Announces a Non-Brokered Private Placement of $3.2 million

Immunovaccine Retains B & D Capital Partners For Strategic Investor Relations Services

Immunovaccine Reports Positive Results from Two Anthrax Studies

Immunovaccine Announces Management Team Changes

Immunovaccine Announces Financial Results for the Quarter Ended June 30, 2013

IIROC Trading Resumption - IMV

IMV Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

(IMV) News

(IMV)

Professional-Grade Tools, for Individual Investors.

IMV News

Immunovaccine Grants Stock Options

Immunovaccine to Present at 6th Annual Biotech Showcase Conference

Immunovaccine to Present at 6th Annual Biotech Showcase Conference

Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors

Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013

Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013

Immunovaccine Raises $4.2 Million in Private Placement

Immunovaccine Announces a Non-Brokered Private Placement of $3.2 million

Immunovaccine Retains B & D Capital Partners For Strategic Investor Relations Services

Immunovaccine Reports Positive Results from Two Anthrax Studies

Immunovaccine Announces Management Team Changes

Immunovaccine Announces Financial Results for the Quarter Ended June 30, 2013

IIROC Trading Resumption - IMV

IMV Discussion

Your Recent History